59
|
Fotsch C, Bartberger MD, Bercot EA, Chen M, Cupples R, Emery M, Fretland J, Guram A, Hale C, Han N, Hickman D, Hungate RW, Hayashi M, Komorowski R, Liu Q, Matsumoto G, St. Jean DJ, Ursu S, Véniant M, Xu G, Ye Q, Yuan C, Zhang J, Zhang X, Tu H, Wang M. Further Studies with the 2-Amino-1,3-thiazol-4(5H)-one Class of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Reducing Pregnane X Receptor Activity and Exploring Activity in a Monkey Pharmacodynamic Model. J Med Chem 2008; 51:7953-67. [DOI: 10.1021/jm801073z] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- Christopher Fotsch
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Michael D. Bartberger
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Eric A. Bercot
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Michelle Chen
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Rod Cupples
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Maury Emery
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Jenne Fretland
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Anil Guram
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Clarence Hale
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Nianhe Han
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Dean Hickman
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Randall W. Hungate
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Michael Hayashi
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Renee Komorowski
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Qingyian Liu
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Guy Matsumoto
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - David J. St. Jean
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Stefania Ursu
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Murielle Véniant
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Guifen Xu
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Qiuping Ye
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Chester Yuan
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Jiandong Zhang
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Xiping Zhang
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Hua Tu
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| | - Minghan Wang
- Departments of Chemical Research and Development, Metabolic Disorders, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080
| |
Collapse
|